Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
The bacterial CRISPR/Cas9 system allows sequence-specific gene editing in many organisms and holds promise as a tool to generate models of human diseases, for example, in human pluripotent stem cells. CRISPR/Cas9 introduces targeted double-stranded breaks (DSBs) with high efficiency, which are typically repaired by non-homologous end-joining (NHEJ) resulting in nonspecific insertions, deletions or other mutations (indels). DSBs may also be repaired by homology-directed repair (HDR) using a DNA repair template, such as an introduced single-stranded oligo DNA nucleotide (ssODN), allowing knock-in of specific mutations. Although CRISPR/Cas9 is used extensively to engineer gene knockouts through NHEJ, editing by HDR remains inefficient and can be corrupted by additional indels, preventing its widespread use for modelling genetic disorders through introducing disease-associated mutations. Furthermore, targeted mutational knock-in at single alleles to model diseases caused by heterozygous mutations has not been reported. Here we describe a CRISPR/Cas9-based genome-editing framework that allows selective introduction of mono- and bi-allelic sequence changes with high efficiency and accuracy. We show that HDR accuracy is increased dramatically by incorporating silent CRISPR/Cas-blocking mutations along with pathogenic mutations, and establish a method termed 'CORRECT' for scarless genome editing. By characterizing and exploiting a stereotyped inverse relationship between a mutation's incorporation rate and its distance to the DSB, we achieve predictable control of zygosity. Homozygous introduction requires a guide RNA targeting close to the intended mutation, whereas heterozygous introduction can be accomplished by distance-dependent suboptimal mutation incorporation or by use of mixed repair templates. Using this approach, we generated human induced pluripotent stem cells with heterozygous and homozygous dominant early onset Alzheimer's disease-causing mutations in amyloid precursor protein (APP(Swe)) and presenilin 1 (PSEN1(M146V)) and derived cortical neurons, which displayed genotype-dependent disease-associated phenotypes. Our findings enable efficient introduction of specific sequence changes with CRISPR/Cas9, facilitating study of human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While exogenous DNA can be inserted at the target site through homology-directed repair (HDR) mechanism, successful insertion of exogenous DNA is relatively rare and is likely accompanied by loss of the second allele24.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [24]
In the citing paper
“Briefly, the majority of a HDR template’s homology arm sequences are not incorporated with on-target HDR integrations (Paquet et al., 2016)”
From Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies (2020) · cites this paper as Paquet et al., 2016
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
PEAR: a fast and accurate Illumina Paired-End reAd mergeR
Zhang, J., Kobert, K., Flouri, T., & Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt593 · Cited by 4,497
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Goecks, J., Nekrutenko, A., Taylor, J., & The Galaxy Team (2010) · Genome Biology · doi:10.1186/gb-2010-11-8-r86 · Cited by 3,453
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Cited by
Items 101–200 of 935
Wannier, T. M., Ciaccia, P. N., Ellington, A. D., Filsinger, G. T., Isaacs, F. J., Javanmardi, K., Jones, M. A., Kunjapur, A. M., Nyerges, Á., Pál, C., et al. (2021) · Nature Reviews Methods Primers · doi:10.1038/s43586-020-00006-x · Cited by 110
Winters, I. P., Chiou, S., Paulk, N. K., McFarland, C. D., Lalgudi, P. V., Ma, R. K., Lisowski, L., Connolly, A. J., Petrov, D. A., Kay, M. A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01519-y · Cited by 102
A validated gRNA library for CRISPR/Cas9 targeting of the human glycosyltransferase genome
Narimatsu, Y., Joshi, H. J., Yang, Z., Gomes, C., Chen, Y., Lorenzetti, F. C., Furukawa, S., Schjoldager, K. T.-B. G., Hansen, L. H., Clausen, H., et al. (2017) · Glycobiology · doi:10.1093/glycob/cwx101 · Cited by 100
Efficient embryonic homozygous gene conversion via RAD51-enhanced interhomolog repair
Wilde, J. J., Aida, T., del Rosario, R. C. H., Kaiser, T., Qi, P., Wienisch, M., Zhang, Q., Colvin, S. M., & Feng, G. (2021) · Cell · doi:10.1016/j.cell.2021.04.035 · Cited by 102
CRISPR/Cas systems: Delivery and application in gene therapy
Huang, J., Zhou, Y., Li, J., Lü, A., & Liang, C. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.942325 · Cited by 116
Off-Target Editing by CRISPR-Guided DNA Base Editors
Park, S., & Beal, P. A. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00573 · Cited by 97
CRISPR–Cas13 Precision Transcriptome Engineering in Cancer
Granados-Riveron, J. T., & Aquino‐Jarquín, G. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0785 · Cited by 100
“These versatile technologies have been repurposed to inactivate human disease-associated genes or potentially to the wild-type state, showing their enormous potential as both diagnostic and therapeutic tools in several aspects of cancer medicine (2, 3).”
BackgroundPrecise genome editing across kingdoms of life using retron-derived DNA
Lopez, S. C., Crawford, K. D., Lear, S. K., Bhattarai-Kline, S., & Shipman, S. L. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00927-y · Cited by 95
Efficient gene editing in Corynebacterium glutamicum using the CRISPR/Cas9 system
Peng, F., Wang, X., Sun, Y., Dong, G., Yang, Y., Liu, X., & Bai, Z. (2017) · Microbial Cell Factories · doi:10.1186/s12934-017-0814-6 · Cited by 97
Challenges and opportunities in stroke genetics
Malik, R., & Dichgans, M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy068 · Cited by 97
Wang, H., Park, H., Liu, J., & Sternberg, P. W. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.118.200662 · Cited by 105
“First, the efficiency of HDR correlates inversely with the distance between homology arms and the Cas9 cut site (Paquet et al. 2016).”
BackgroundCas9, Cpf1 and C2c1/2/3―What's next?
Nakade, S., Yamamoto, T., & Sakuma, T. (2017) · Bioengineered · doi:10.1080/21655979.2017.1282018 · Cited by 97
“In addition, these variants have been broadened their applications as represented by the CORRECT method, which can modify the targeted single nucleotide precisely with sophisticatedly designed 2-step genome engineering.(27)”
MethodCas9-assisted recombineering in C. elegans : genome editing using in vivo assembly of linear DNAs
Paix, A., Schmidt, H., & Seydoux, G. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw502 · Cited by 88
“HDR in mammalian cells is also a highly local process that favors the incorporation of edits closest to the DSB (23).”
Xu, X., Gao, D., Wang, P., Chen, J., Ruan, J., Xu, J., & Xia, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-30227-w · Cited by 103
Miao, J., Chi, Y., Dong, L., Tyler, B. M., & Liu, X. (2018) · Phytopathology · doi:10.1094/phyto-01-18-0010-r · Cited by 95
Exosome/Liposome-like Nanoparticles: New Carriers for CRISPR Genome Editing in Plants
Alghuthaymi, M. A., Ahmad, A., Khan, Z., Khan, S. H., Ahmed, F. K., Faiz, S., Nepovimova, E., Kuča, K., & Abd-Elsalam, K. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147456 · Cited by 83
Teixeira, M., Py, B. F., Bosc, C., Laubreton, D., Moutin, M., Marvel, J., Flamant, F., & Markossian, S. (2018) · Scientific Reports · doi:10.1038/s41598-017-18826-5 · Cited by 100
Li, S., Li, J., Zhang, J., Du, W., Fu, J., Sutar, S. H., Zhao, Y., & Xia, L. (2018) · Journal of Experimental Botany · doi:10.1093/jxb/ery245 · Cited by 86
“SDSA has been proposed as a repair mechanism when the single-stranded oligo DNA nucleotides (ssODNs) are used as the DRT (Paquet et al., 2016; Richardson et al., 2016; Kan et al., 2017).”
MethodBi-PE: bi-directional priming improves CRISPR/Cas9 prime editing in mammalian cells
Tao, R. X., Wang, Y., Jiao, Y., Hu, Y. F., Li, L., Jiang, L., Zhou, L., Qu, J., Chen, Q., & Yao, S. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac506 · Cited by 87
Click editing enables programmable genome writing using DNA polymerases and HUH endonucleases
Ferreira da Silva, J., Tou, C. J., King, E. M., Eller, M. L., Rufino-Ramos, D., Ma, L., Cromwell, C. R., Metovic, J., Benning, F. M. C., Chao, L. H., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-024-02324-x · Cited by 82
“16a,b), consistent with prior results that suggest PAM disruption prevents the CE from retargeting the locus after edit installation 63–65 .”
Wang, L., Li, Z., Wang, L., Liu, C., Sun, X., Feng, G., Wang, J., Li, Y., Qiao, L., Nie, H., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.05.014 · Cited by 81
Raveux, A., Vandormael‐Pournin, S., & Cohen‐Tannoudji, M. (2017) · Scientific Reports · doi:10.1038/srep42661 · Cited by 84
“ssODN Pronucleus 100/50† 20 2 69/109 (63) 63 9a (14) 52 (82) 9 (14) 24 (38)”
Precise genome-editing in human diseases: mechanisms, strategies and applications
Zheng, Y., Li, Y., Zhou, K., Li, T., VanDusen, N. J., & Hua, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01750-2 · Cited by 105
Tang, C. S.-M., Li, P., Lai, F. P.-L., Fu, X., Lau, S.-T., So, M.-T., Lui, K. N.-C., Li, Z., Zhuang, X., Yu, M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.09.012 · Cited by 86
FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling
Arias, J., Jarazo, J., Qing, X., Walter, J., Gomez‐Giro, G., Nickels, S., Zaehres, H., Schöler, H. R., & Schwamborn, J. C. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.08.026 · Cited by 88
“The sequence conversion from an endogenous sequence to that carried in donor templates extends from 400 bp in dsDNA (Elliott and Jasin, 2001) to 30 bp in ssDNA donors (Paquet et al., 2016).”
BackgroundMethodCao, J., Huang, M., Guo, L., Zhu, L., Hou, J., Zhang, L., Pero, A., Ng, S., Gaamouch, F. E., Elder, G. A., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0824-3 · Cited by 86
“These NPCs were purified by MACS for CD271 - /CD133 + 53 and differentiated to cortical neurons 55, 56 and a homogeneous population of astrocytes 54, 57 before subjected to viral transfection and confocal microscopy analysis.”
Guernet, A. A., Mungamuri, S. K., Cartier, D., Sachidanandam, R., Jayaprakash, A. D., Adriouch, S., Vézain, M., Charbonnier, F., Rohkin, G., Coutant, S., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.06.017 · Cited by 89
“Of note, whereas in our model we could not discriminate between homo- or heterozygous mutations, new strategies have been recently developed to specifically target either one or both alleles (Paquet et al., 2016).”
BackgroundEndogenous Fluorescence Tagging by CRISPR
Bukhari, H., & Müller, T. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.08.004 · Cited by 89
Development and Application of CRISPR/Cas in Microbial Biotechnology
Ding, W., Zhang, Y., & Shi, S. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00711 · Cited by 85
Serneels, L., T’Syen, D., Pérez‐Benito, L., Theys, T., Holt, M. G., & Strooper, B. D. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00399-z · Cited by 92
Application of CRISPR/Cas9 in Alzheimer’s Disease
Lu, L., Xi, Y., Cai, Y., Sun, M., & Yang, H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.803894 · Cited by 90
“In 2016, Paquet et al. (2016) introduced mutations of amyloid precursor protein (APP) and PSEN1 which cause AD, into human iPSCs.”
BackgroundSimultaneous reprogramming and gene editing of human fibroblasts
Howden, S. E., Thomson, J. A., & Little, M. H. (2018) · Nature Protocols · doi:10.1038/nprot.2018.007 · Cited by 82
Martín-Maestro, P., Sproul, A. A., Martínez, H., Paquet, D., Gerges, M., Noggle, S., & Starkov, A. A. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01665-y · Cited by 79
Self-citationSanjurjo-Soriano, C., Erkilic, N., Baux, D., Mamaeva, D., Hamel, C. P., Meunier, I., Roux, A.-F., & Kalatzis, V. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2019.11.016 · Cited by 79
gRNA validation for wheat genome editing with the CRISPR-Cas9 system
Arndell, T., Sharma, N., Langridge, P., Baumann, U., Watson‐Haigh, N. S., & Whitford, R. (2019) · BMC Biotechnology · doi:10.1186/s12896-019-0565-z · Cited by 83
NitroSynapsin ameliorates hypersynchronous neural network activity in Alzheimer hiPSC models
Ghatak, S., Dolatabadi, N., Gao, R., Wu, Y., Scott, H. R., Trudler, D., Sultan, A., Ambasudhan, R., Nakamura, T., Masliah, E., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0776-7 · Cited by 81
CRISPR/Cas9‐Mediated Fluorescent Tagging of Endogenous Proteins in Human Pluripotent Stem Cells
Sharma, A., Toepfer, C. N., Ward, T. L., Wasson, L. K., Agarwal, R., Conner, D. A., Hu, J. H., & Seidman, C. E. (2018) · Current Protocols in Human Genetics · doi:10.1002/cphg.52 · Cited by 81
“Previous reports have suggested that having a targeted DSB within 30 bp of the mutation start site can enhance the HDR process, with breaks closer to the mutation site resulting in higher rates of genome editing (Paquet et al., 2016).”
BackgroundCutting back malaria: CRISPR/Cas9 genome editing of Plasmodium
Lee, M., Lindner, S. E., Lopez-Rubio, J.-J., & Llinás, M. (2019) · Briefings in Functional Genomics · doi:10.1093/bfgp/elz012 · Cited by 82
“with the fewest predicted off-target effects [37].”
A functional genetic toolbox for human tissue-derived organoids
Sun, D., Evans, L., Perrone, F., Sokleva, V., Lim, K., Rezakhani, S., Lutolf, M., Zilbauer, M., & Rawlins, E. L. (2021) · eLife · doi:10.7554/elife.67886 · Cited by 71
“…design to facilitate efficient and consistent gene targeting: (1) protospacer adjacent motif (PAM) sequence mutated to prevent editing by ssRNP (Paquet et al., 2016); (2) 700 nt to 1000 nt length of each homologous arm (Yao et al., 2018); (3) minimal plasmid size to maximise delivery into…”
BackgroundPreman, P., Julia, T. C. W., Calafate, S., Snellinx, A., Alfonso-Triguero, M., Corthout, N., Munck, S., Thal, D. R., Goate, A., Strooper, B. D., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00487-8 · Cited by 85
Strategies for genetic manipulation of adult stem cell-derived organoids
Menche, C., & Farin, H. F. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00609-8 · Cited by 77
Bahmad, H. F., Hadadeh, O., Chamaa, F., Cheaito, K. A., Darwish, B., Makkawi, A.-K., & Abou-Kheir, W. G. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00050 · Cited by 76
“Remarkably, Paquet et al. (2016) established a procedure that allows the introduction of specific point mutations into iPSCs using CRISPR, thus generating human iPSCs with specific combinations of homozygous and heterozygous early-onset Alzheimer’s-associated mutations.”
BackgroundMatsumoto, R., Suga, H., Aoi, T., Bando, H., Fukuoka, H., Iguchi, G., Narumi, S., Hasegawa, T., Muguruma, K., Ogawa, W., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127378 · Cited by 78
“To improve the efficiency of homologous recombination, synonymous mutation was included in ssODN sequence as previously described (55). iPSCs were transfected with Cas9-and sgRNA-expressing plasmid (pX458 or pX459, Addgene plasmids 48138 and 62988) and ssODN using Lipofectamine Stem solution (0.25%…”
MethodInfluentialControl of gene editing by manipulation of DNA repair mechanisms
Danner, E. W., Bashir, S., Yumlu, S., Wurst, W., Wefers, B., & Kühn, R. (2017) · Mammalian Genome · doi:10.1007/s00335-017-9688-5 · Cited by 80
“Further, modulation of this distance can be used to generate heterozygous and homozygous knockins (Paquet et al. 2016).”
BackgroundGuo, Q. J., Mintier, G. A., Ma-Edmonds, M., Storton, D., Wang, X., Xiao, X., Kienzle, B. K., Zhao, D., & Feder, J. N. (2018) · Scientific Reports · doi:10.1038/s41598-018-20358-5 · Cited by 69
Optimized knock-in of point mutations in zebrafish using CRISPR/Cas9
Prykhozhij, S. V., Fuller, C. J., Steele, S. L., Veinotte, C. J., Razaghi, B., Robitaille, J. M., McMaster, C. R., Shlien, A., Malkin, D. M., & Berman, J. N. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky674 · Cited by 71
Non human primate models for Alzheimer’s disease-related research and drug discovery
Dam, D. V., & Deyn, P. P. D. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1271320 · Cited by 77
“The bacterial CRISPR/Cas9 system allows sequence-specific gene editing in many cells and organisms and holds promise as a tool to generate innovating models of human diseases [193].”
BackgroundNew synthetic biology tools for metabolic control
Lv, X., Hueso‐Gil, Á., Bi, X., Wu, Y., Liu, Y., Liu, L., & Ledesma‐Amaro, R. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102724 · Cited by 67
Xu, W., Zhang, S., Qin, H., & Yao, K. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05957-3 · Cited by 84
APOBEC: From mutator to editor
Yang, B., Li, X., Lei, L., & Chen, J. (2017) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2017.04.009 · Cited by 75
Creating cell and animal models of human disease by genome editing using CRISPR/Cas9
Zarei, A., Razban, V., Hosseini, S. E., & Tabei, K. (2019) · The Journal of Gene Medicine · doi:10.1002/jgm.3082 · Cited by 74
One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids
Geurts, M. H., Gandhi, S., Boretto, M. G., Akkerman, N., Derks, L. L. M., van Son, G., Celotti, M., Harshuk-Shabso, S., Peci, F., Begthel, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40701-3 · Cited by 66
Simkin, D., Papakis, V., Bustos, B. I., Ambrosi, C. M., Ryan, S. J., Baru, V., Williams, L. A., Dempsey, G. T., McManus, O. B., Landers, J. E., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.02.008 · Cited by 72
“Nevertheless, most protocols still require large-scale screening of 25–100 isolated clones (Paquet et al., 2016).”
BackgroundMethodCRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
Rahman, M. U., Bilal, M., Shah, J. A., Kaushik, A. K., Teissèdre, P., & Kujawska, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061252 · Cited by 70
Efficient allelic-drive in Drosophila
Guichard, A., Haque, T., Bobik, M., Xu, X., Klanseck, C. F., Kushwah, R. B. S., Berni, M. A., Kaduskar, B., Gantz, V. M., & Bier, E. (2019) · Nature Communications · doi:10.1038/s41467-019-09694-w · Cited by 71
The CRISPR toolbox in medical mycology: State of the art and perspectives
Morio, F., Lombardi, L., & Butler, G. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008201 · Cited by 68
“This was first achieved in mammalian cell lines using mixed repair templates carrying a different set of mutations or, alternatively, by exploiting the cut-to-mutation distance (the efficiency of mutation incorporation rapidly falls with increasing distance from the Cas9 cleavage site) [69].”
BackgroundCRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer’s Disease—A Narrative Review
Barman, N. C., Khan, M. N. M., Islam, M., Nain, Z., Roy, R. K., Haque, A., & BARMAN, S. K. (2020) · Neurology and Therapy · doi:10.1007/s40120-020-00218-z · Cited by 69
“CRISPR-Cas9 has been used to make a model of the APP and PSEN1 mutations and displayed a precise strategy of genome editing using gRNA synthesis [22].”
BackgroundMethodScarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection
Steyer, B., Bu, Q., Cory, E., Jiang, K., Duong, S., Sinha, D., Steltzer, S. S., Gamm, D. M., Chang, Q., & Saha, K. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.12.004 · Cited by 72
“This limitation is shared by all protocols that employ clonal isolation (Hazelbaker et al., 2017), and may be an even greater concern in protocols that require more than one clonal selection step (Paquet et al., 2016; Shy et al., 2016).”
BackgroundNon-viral strategies for delivering genome editing enzymes
Li, J., Røise, J. J., He, M., Das, R., & Murthy, N. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.004 · Cited by 68
Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple Candida Species
Lombardi, L., Oliveira-Pacheco, J., & Butler, G. (2019) · mSphere · doi:10.1128/msphere.00125-19 · Cited by 72
“Alternatively, cells 223 transformed with a mixture of two different repair templates can incorporate a different 224 template at each allele (38).”
BackgroundInfluentialOptimized knock-in of point mutations in zebrafish using CRISPR/Cas9
Prykhozhij, S. V., Fuller, C. J., Steele, S. L., Veinotte, C. J., Razaghi, B., Robitaille, J. M., McMaster, C. R., Shlien, A., Malkin, D. M., & Berman, J. N. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky512 · Cited by 69
“The findings in two recent papers (12,13) suggest the strong inverse relationship between knock-in efficiency and the distance of the modification to the cut site.”
BackgroundMethodInfluentialDelivering on the promise of gene editing for cystic fibrosis
Hodges, C. A., & Conlon, R. A. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.11.005 · Cited by 69
“The likelihood that a new nucleotide will be incorporated into the final sequence is greatest if the change is within a handful of nucleotides of the break.(38) This strong distancedependence may be due to mismatch repair and processive cellular exonucleases.”
BackgroundAn update on precision genome editing by homology-directed repair in plants
Chen, J., Li, S., He, Y., Li, J., & Xia, L. (2022) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiac037 · Cited by 72
Ciliopathy patient variants reveal organelle-specific functions for TUBB4B in axonemal microtubules
Dodd, D. O., Méchaussier, S., Yeyati, P. L., McPhie, F., Anderson, J. R., Khoo, C. J., Shoemark, A., Gupta, D. K., Attard, T., Zariwala, M. A., et al. (2024) · Science · doi:10.1126/science.adf5489 · Cited by 72
“Silent mutations were included to block the re-cutting as reported to increase the HDR accuracy and efficiency (73).”
BackgroundAccurate measurement of fast endocytic recycling kinetics in real time
Jonker, C. T. H., Deo, C., Zager, P. J., Tkachuk, A. N., Weinstein, A. M., Rodriguez-Boulan, E. J., Lavis, L. D., & Schreiner, R. P. (2019) · Journal of Cell Science · doi:10.1242/jcs.231225 · Cited by 65
“The insert consisted of HaloTag (HT7; Encell et al., 2013) fused to the last codon of TfR via an eight amino acid linker, GPDLVPRG, flanked by homology arms (about 375 bp each) positioned such that there are no extended overhangs on the chromosomal insertion site (Paquet et al., 2016).”
MethodSpG and SpRY variants expand the CRISPR toolbox for genome editing in zebrafish
Liang, F., Zhang, Y., Li, L., Yang, Y., Fei, J., Liu, Y., & Qin, W. (2022) · Nature Communications · doi:10.1038/s41467-022-31034-8 · Cited by 64
Chou, S., Yang, P., Ban, Q., Yang, Y. P., Wang, M., Chien, C., Chen, S. J., Sun, N., Zhu, Y., Liu, H., et al. (2020) · Advanced Science · doi:10.1002/advs.201903432 · Cited by 62
Co-incident insertion enables high efficiency genome engineering in mouse embryonic stem cells
Shy, B. R., MacDougall, M. S., Clarke, R., & Merrill, B. J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw685 · Cited by 70
“Recently, efficient precise editing of human pluripotent cells was described via a method named CORRECT, which uses Cas9 and ssODN to generate small homozygous mutations (33).”
MethodMultiple sgRNAs with overlapping sequences enhance CRISPR/Cas9-mediated knock-in efficiency
Jang, D. E., Lee, J. Y., Lee, J. H., Koo, O. J., Bae, H. S., Jung, M. H., Bae, J. H., Hwang, W. S., Chang, Y. J., Lee, Y. H., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0037-x · Cited by 65
Idoko-Akoh, A., Taylor, L., Sang, H., & McGrew, M. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-33244-x · Cited by 65
Editing Silicon Transporter Genes to Reduce Arsenic Accumulation in Rice
Xu, X., Sun, S., Zhang, W., Tang, Z., & Zhao, F. J. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.3c10763 · Cited by 59
Saurat, N. G., Minotti, A. P., Rahman, M. T., Sikder, T., Zhang, C., Cornacchia, D., Jungverdorben, J., Ciceri, G., Betel, D., & Studer, L. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.06.001 · Cited by 64
Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components
Wu, F., Li, N., Xiao, Y., Palanki, R., Yamagata, H. M., Mitchell, M. J., & Han, X. (2025) · Small Methods · doi:10.1002/smtd.202401632 · Cited by 73
CRISPR/Cas9-mediated genome editing in plants
Liu, X., Xie, C., Si, H., & Yang, J. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.009 · Cited by 68
Dewari, P. S., Southgate, B., McCarten, K., Monogarov, G., O’Duibhir, E., Quinn, N., Tyrer, A., Leitner, M.-C., Plumb, C., Kalantzaki, M., et al. (2018) · eLife · doi:10.7554/elife.35069 · Cited by 64
Microhomology-assisted scarless genome editing in human iPSCs
Kim, S.-I., Matsumoto, T., Kagawa, H., Nakamura, M., Hirohata, R., Ueno, A., Ohishi, M., Sakuma, T., Soga, T., Yamamoto, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03044-y · Cited by 60
Ma, L., Ruan, J., Song, J. W., Wen, L., Yang, D., Zhao, J., Xia, X., Chen, Y. E., Zhang, J., & Xu, J. (2020) · Nature Communications · doi:10.1038/s41467-020-19842-2 · Cited by 61
Targeting Alzheimer's disease with gene and cell therapies
Loera‐Valencia, R., Piras, A., Ismail, M.-A.-M., Manchanda, S., Eyjolfsdottir, H., Saido, T. C., Johansson, J., Eriksdotter, M., Winblad, B. G., & Nilsson, P. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12759 · Cited by 60
Gowrishankar, S., Lyons, L., Rafiq, N. M., Roczniak-Ferguson, A., De Camilli, P., & Ferguson, S. M. (2021) · Molecular Biology of the Cell · doi:10.1091/mbc.e20-06-0382 · Cited by 62
“…genome editing tools has opened up new opportunities for investigating the impact of targeted genetic perturbations on neuronal cell biology (Dolmetsch and Geschwind, 2011; Zhang et al. , 2013; Paquet et al. , 2016; Wang et al. , 2017; Fernandopulle et al. , 2018; Tian et al. , 2019).”
Novel fragile X syndrome 2D and 3D brain models based on human isogenic FMRP-KO iPSCs.
Brighi, C., Salaris, F., Soloperto, A., Cordella, F., Ghirga, S., de Turris, V., Rosito, M., Porceddu, P. F., D’Antoni, C., Reggiani, A., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03776-8 · Cited by 56
Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases
Kolli, N., Lü, M., Maiti, P., Rossignol, J., & Dunbar, G. L. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.07.007 · Cited by 64
“Paquet et al. (2016) have created human iPSCs which display genotype-dependent (APP and presenilin mutation) disease-associated phenotypes.”
Rose, J. C., Popp, N. A., Richardson, C. D., Stephany, J. J., Mathieu, J., Wei, C. T., Corn, J. E., Maly, D. J., & Fowler, D. M. (2020) · Nature Communications · doi:10.1038/s41467-020-16542-9 · Cited by 58
Methods and applications of CRISPR/Cas system for genome editing in stem cells
Yang, G., & Huang, X. (2019) · Cell Regeneration · doi:10.1016/j.cr.2019.08.001 · Cited by 56
“Recent studies show that modeling the clinical pathogenic mutations can recapitulate the specificity of neurodegenerative diseases, such as amyloid-b (Ab) generation in Alzheimer's disease (AD) [38,144,145].”
BackgroundDecorating chromatin for enhanced genome editing using CRISPR-Cas9
Chen, E., Lin-Shiao, E., Trinidad, M. I., Doost, M. S., Colognori, D., & Doudna, J. A. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204259119 · Cited by 60
“org introduction of a desired mutation at improved efficiency at a broader range of targets, whereas a silent PAM-blocking mutation may not be available at some exonic target sites (48).”
BackgroundRecent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem Cells
Lotfi, M., Rad, D. M., Mashhadi, S., Ashouri, A., Mojarrad, M., Mozaffari‐Jovin, S., Farrokhi, S., Hashemi, M., Lotfi, M., Warkiani, M. E., et al. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10585-3 · Cited by 65
Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9
Yumlu, S., Stumm, J., Bashir, S., Dreyer, A.-K., Lisowski, P., Danner, E. W., & Kühn, R. (2017) · Methods · doi:10.1016/j.ymeth.2017.05.009 · Cited by 70
“The CRISPR/Cas9 system can be used for modification of both copies of a target gene, or restricted to induce changes only in alleles of interest by selective gene editing based on haplotype-specific target sites [23] [24] [25].”
MethodLish, A. M., Grogan, E. F. L., Benoit, C. R., Pearse, R. V., Heuer, S. E., Luquez, T., Orme, G. A., Galle, P. C., Milinkeviciute, G., Green, K. N., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.03.034 · Cited by 59
Li, S., & Xia, L. (2019) · aBIOTECH · doi:10.1007/s42994-019-00009-7 · Cited by 60
Optimized CRISPR-mediated gene knockin reveals FOXP3-independent maintenance of human Treg identity
Lam, A. J., Lin, D. T. S., Gillies, J. K., Uday, P., Pesenacker, A. M., Kobor, M. S., & Levings, M. K. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109494 · Cited by 52
“If using gene knockin to achieve uniform gene KO, however, monoallelic reporter integration may be sufficient because cells that underwent HDR at one allele frequently exhibit error-prone DNA repair at the other allele (Paquet et al., 2016; Wassef et al., 2017; Zhang et al., 2014).”
Eggenschwiler, R., Moslem, M., Fráguas-Eggenschwiler, M., Galla, M., Papp, O., Naujock, M., Fonfara, I., Gensch, I., Wähner, A., Beh-Pajooh, A., et al. (2016) · Scientific Reports · doi:10.1038/srep38198 · Cited by 52
Smith, T. A., Lopez-Perez, G. S., Herneisen, A. L., Shortt, E., & Lourido, S. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01104-0 · Cited by 57
“Since the efficiency of recombination decreases with the distance of the homology regions from the double-stranded break, we selected gRNAs that cut within a 50 bp window downstream of the stop codon 44–47 .”
Towards the Clinical Application of Gene Therapy for Genetic Inner Ear Diseases
Lahlou, G., Calvet, C., Giorgi, M., Lecomte, M.-J., & Safieddine, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031046 · Cited by 57
Liu, Z., Reino, E. J. G., Harschnitz, O., Guo, H., Chan, Y., Khobrekar, N. V., Hasek, M. L., Dobbs, K., Rinchai, D., Materna, M., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.ade2860 · Cited by 58
Raković, A., Domingo, A., Grütz, K., Kulikovskaja, L., Capetian, P., Cowley, S. A., Lenz, I., Brüggemann, N., Rosales, R. L., Jamora, R. D. G., et al. (2018) · Movement Disorders · doi:10.1002/mds.27441 · Cited by 54
“Genome editing using CRISPR/Cas9 technology allows sequence-specific genome manipulations in many organisms and cellular models.(7) This method involves introduction of targeted double-stranded breaks in DNA, which are typically repaired by nonhomologous end-joining (NHEJ) and result in insertions, deletions, or nucle…”
MethodThe Problem of the Low Rates of CRISPR/Cas9-Mediated Knock-ins in Plants: Approaches and Solutions
Розов, С. М., Permyakova, N. V., & Дейнеко, Е. В. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133371 · Cited by 57
“This scheme made it possible to avoid repeated cutting and two- to ten-fold elevation in the HDR rate [61].”
BackgroundMethodFleischer, A., Vallejo‐Díez, S., Martín‐Fernández, J. M., Sánchez‐Gilabert, A., Castresana, M., del Pozo, Á., Esquisabel, A., Ávila, S., Castrillo, J. L., Gaínza, E., et al. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.04.005 · Cited by 56
Gene therapy for cystic fibrosis: Challenges and prospects
Sui, H., Xu, X., Su, Y., Gong, Z., Yao, M., Liu, X., Zhang, T., Jiang, Z., Bai, T., Wang, J., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1015926 · Cited by 60
“With the provided template for gene correction, the HDR response enables homologous recombination (HR) between the template and the target gene at the cleaved site to introduce desired correction, insertion, or deletion (Paquet et al., 2016).”
MethodGenome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease
Giau, V. V., Lee, H., Shim, K. H., Bagyinszky, E., & An, S. S. A. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s155145 · Cited by 56
Synergistic gene editing in human iPS cells via cell cycle and DNA repair modulation
Maurissen, T. L., & Woltjen, K. (2020) · Nature Communications · doi:10.1038/s41467-020-16643-5 · Cited by 61
CRISPR base editing and prime editing: DSB and template-free editing systems for bacteria and plants
Abdullah, A., Jiang, Z., Hong, X., Zhang, S., Yao, R., & Xiao, Y. (2020) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2020.08.003 · Cited by 56
“NHEJ has been used for gene disruption by the introduction of indels or translocations, while HDR has been used in combination with donor DNA templates for precise replacements, deletions, insertions or point mutations [9].”
Method
Metadata
- Authors
- Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M.
- Affiliations
- Rockefeller University (US)
- New York Stem Cell Foundation (US)
- Cornell University (US)
- Venue
- Nature
- Published
- 2016-04-27
- Volume
- 533
- Issue
- 7601
- Pages
- 125-129
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2343876552
- Cited by
- 951
- References
- 49
- Citations by year
- 2026: 58 · 2025: 56 · 2024: 90 · 2023: 87 · 2022: 104 · 2021: 106 · 2020: 125 · 2019: 93 · 2018: 111 · 2017: 91 · 2016: 29
- FWCI
- 56.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (UL1TR000043)
- National Institute of General Medical Sciences (T32GM007739)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, homology-directed repair, non-homologous end joining, amyloid precursor protein, presenilin 1, early-onset Alzheimer's disease, induced pluripotent stem cells, disease modeling
- MeSH terms
- RNA, Guide, CRISPR-Cas Systems, Adolescent, Alleles, Alzheimer Disease, Animals, Base Sequence, DNA Repair, Female, Genes, Dominant, Genetic Engineering, Heterozygote, Homozygote, Humans, Male, Mutation, Substrate Specificity, Templates, Genetic, Mutagenesis, Amyloid beta-Protein Precursor, Sequence Homology, Age of Onset, Mice, Presenilins, DNA Cleavage, DNA Breaks, Double-Stranded, Genetic Association Studies, Induced Pluripotent Stem Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.